THE U.S. PHARMACOPEIAL CONVENTION H-1B Visa Sponsorship & Salary Data

The median H-1B salary at THE U.S. PHARMACOPEIAL CONVENTION is $122,280, based on 58 certified filings from FY 2020 to FY 2025. This is 2% higher than the national H-1B median salary of $120,000. Compensation at THE U.S. PHARMACOPEIAL CONVENTION reflects their market positioning, with entry-level roles starting around $99,000 and senior positions reaching $151,861 or higher. These figures represent base salaries in LCA filings and may not include bonuses, equity grants, or other compensation common at large employers.

Salaries at THE U.S. PHARMACOPEIAL CONVENTION range from $89,300 at the 10th percentile to $151,861 at the 90th percentile, showing a $62,561 spread across experience levels and roles. The 25th percentile is $99,000 and the 75th percentile is $135,000.

Yes, THE U.S. PHARMACOPEIAL CONVENTION actively sponsors H-1B visas and has been a consistent participant in the H-1B program. They have filed 63 H-1B labor condition applications from FY 2020 to FY 2025, demonstrating ongoing commitment to hiring international talent. With 58 certified applications and a 0% denial rate, THE U.S. PHARMACOPEIAL CONVENTION maintains a strong track record for H-1B sponsorship. The company sponsors positions across multiple job categories and locations, making them a viable option for professionals seeking H-1B visa sponsorship.

In the most recent fiscal year (FY 2025), THE U.S. PHARMACOPEIAL CONVENTION filed 5 H-1B applications, with 5 certified and 0 denied. Over 6 years of data, THE U.S. PHARMACOPEIAL CONVENTION has consistently demonstrated commitment to H-1B sponsorship.

Note: These are Labor Condition Applications (LCAs) filed with the Department of Labor, which is a prerequisite for H-1B petitions. The actual number of H-1B petitions filed with USCIS may differ.

THE U.S. PHARMACOPEIAL CONVENTION's LCA (Labor Condition Application) denial rate is 0%, with 0 out of 63 applications denied across all years. This translates to a 100.0% certification rate, which indicates how successfully the company prepares and files H-1B applications. A lower denial rate suggests better compliance with Department of Labor requirements, proper wage documentation, and accurate job classification. Prospective H-1B applicants should consider this approval rate alongside other factors like salary, job role, and location when evaluating THE U.S. PHARMACOPEIAL CONVENTION as a potential H-1B sponsor.

This is an excellent approval rate, indicating THE U.S. PHARMACOPEIAL CONVENTION has strong H-1B sponsorship practices and typically meets DOL requirements. Applicants can feel confident in the company's H-1B track record.

THE U.S. PHARMACOPEIAL CONVENTION sponsors H-1B visas for various specialty occupation positions requiring at least a bachelor's degree. Based on 58 certified filings, the most commonly sponsored job titles reflect the company's primary business functions and talent needs. These positions typically require specialized knowledge in fields like technology, engineering, finance, or scientific research. Understanding which roles THE U.S. PHARMACOPEIAL CONVENTION most frequently sponsors can help job seekers target their applications effectively.

Most common H-1B job titles at THE U.S. PHARMACOPEIAL CONVENTION:

The most frequently sponsored role is Senior Software Engineer with 10 filings at a median salary of $129,143. This is followed by Senior Research Scientist (7 filings) and Developer III.

THE U.S. PHARMACOPEIAL CONVENTION's H-1B positions are distributed across multiple U.S. locations, with concentration in major metropolitan areas and tech hubs. Geographic distribution often reflects company office locations, client sites, and regional market demands. Location significantly impacts H-1B salary due to varying cost of living and local wage requirements. Understanding where THE U.S. PHARMACOPEIAL CONVENTION sponsors H-1B workers can help candidates target specific offices and negotiate appropriate compensation for each market.

Top THE U.S. PHARMACOPEIAL CONVENTION H-1B locations:

The largest H-1B hub for THE U.S. PHARMACOPEIAL CONVENTION is Rockville, MD with 58 filings at a median salary of $122,280.

THE U.S. PHARMACOPEIAL CONVENTION's median H-1B salary has increased by +55% from FY 2020 ($89,300) to FY 2025 ($138,730). Tracking salary trends over time reveals how THE U.S. PHARMACOPEIAL CONVENTION adjusts compensation to remain competitive in the H-1B labor market. Salary growth typically reflects inflation adjustments, increased demand for specialized skills, and evolving prevailing wage requirements. These historical trends can help applicants understand future salary expectations and negotiate appropriately when considering H-1B opportunities at THE U.S. PHARMACOPEIAL CONVENTION.

Year-by-year breakdown:

• FY 2021: $114,296 (7 certified)
• FY 2022: $119,904 (16 certified)
• FY 2023: $135,000 (13 certified)
• FY 2024: $125,611 (8 certified)
• FY 2025: $138,730 (5 certified)

This 55% growth reflects strong compensation adjustments at THE U.S. PHARMACOPEIAL CONVENTION, keeping pace with market demands for H-1B talent.

THE U.S. PHARMACOPEIAL CONVENTION primarily files H-1B applications at Wage Level III, accounting for 45% of their filings. DOL wage levels range from Level I (entry-level, 17th percentile of local wages) to Level IV (expert, 67th percentile). Wage level determines both salary requirements and, under recent H-1B rules, lottery selection priority. Higher wage levels receive preference in the H-1B lottery, making THE U.S. PHARMACOPEIAL CONVENTION's wage level distribution an important factor for prospective applicants assessing their chances of H-1B selection.

With 97% of positions at Level II or higher, THE U.S. PHARMACOPEIAL CONVENTION typically offers competitive wages above entry-level. Higher wage levels receive priority in the H-1B lottery.

THE U.S. PHARMACOPEIAL CONVENTION's median H-1B salary of $122,280 is 2% higher than the national H-1B median of $120,000 across all employers and industries. This comparison provides context for evaluating THE U.S. PHARMACOPEIAL CONVENTION's competitiveness in attracting H-1B talent. Keep in mind that industry, location, and job function significantly impact salary levels. Tech companies and financial institutions typically offer higher H-1B salaries than other sectors, while salaries in major metros like San Francisco and New York exceed those in smaller markets. Compare THE U.S. PHARMACOPEIAL CONVENTION's offerings with similar companies in your field for a more accurate assessment.

THE U.S. PHARMACOPEIAL CONVENTION offers above-average H-1B compensation. Combined with their 58 certified filings and 0% denial rate, they demonstrate solid H-1B sponsorship practices.

Recent H-1B rule changes have increased filing fees and introduced wage-level prioritization in the lottery. THE U.S. PHARMACOPEIAL CONVENTION's higher proportion of Level III-IV positions (90%) may benefit from wage-based lottery prioritization.

With 58 certified filings, THE U.S. PHARMACOPEIAL CONVENTION invests significantly in H-1B sponsorship. The company's 0% denial rate suggests strong compliance with H-1B requirements and documentation standards.

Note: H-1B regulations are subject to change. Fees shown are estimates based on 2024 USCIS fee schedules. Actual costs may vary based on company size, premium processing, and future rule changes.